Bio-Path Holdings Inc
BPTH
BPTH was delisted on the 18th of February, 2025.
26 hedge funds and large institutions have $3.98M invested in Bio-Path Holdings Inc in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 5 reducing their positions, and 11 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
20% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 5
21% less funds holding
Funds holding: 33 → 26 (-7)
34% less capital invested
Capital invested by funds: $6.02M → $3.98M (-$2.04M)
45% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 11
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Renaissance Technologies
New York
|
+$106K |
| 2 |
HighTower Advisors
Chicago,
Illinois
|
+$45.3K |
| 3 |
LTFS
Ladenburg Thalmann Financial Services
Miami,
Florida
|
+$35.7K |
| 4 |
TSS
Two Sigma Securities
New York
|
+$19.2K |
| 5 |
BP
BBR Partners
New York
|
+$5.49K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Legal & General Group
London,
United Kingdom
|
-$681K |
| 2 |
SM
Sabby Management
Miami Beach,
Florida
|
-$462K |
| 3 |
ECM
Element Capital Management
New York
|
-$154K |
| 4 |
Millennium Management
New York
|
-$145K |
| 5 |
PP
Paloma Partners
Greenwich,
Connecticut
|
-$125K |
BPTH Hedge Fund Activity: Q3 2017 in Review
26 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Bio-Path Holdings Inc (BPTH) for Q3 2017, worth a combined $3.98M — down 34% from $6.02M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of BPTH and 6 opened new positions — a net loss of 5 holders — while 5 trimmed existing stakes and 4 added.
The largest buyer was Renaissance Technologies, adding an estimated $106K. The largest seller was Legal & General Group, exiting entirely with an estimated $681K sold.
- 26 institutional investors held Bio-Path Holdings Inc (BPTH) as of Q3 2017, down from 33 in Q2 2017.
- Funds reported $3.98M of Bio-Path Holdings Inc stock for Q3 2017, down 34% quarter-over-quarter.
- 6 funds opened new Bio-Path Holdings Inc positions in Q3 2017 and 11 closed out, a net change of -5 holders.
- The largest Bio-Path Holdings Inc buyer in Q3 2017 was Renaissance Technologies, an estimated $106K added.
- The largest Bio-Path Holdings Inc seller in Q3 2017 was Legal & General Group, an estimated $681K sold.
Based on aggregated 13F filings for Q3 2017.